INS and diabetes mellitus: Confirmation of the ability of HSA to bind insulin and its fragments and reduce their susceptibility to aggregation might then provide the basis for further research on the use of HSA as DDS for peptidic inhibitors of the insulin aggregation process, which could lead to innovative approaches to diabetes treatment.